Suppr超能文献

[肠衰竭:从适应到移植]

[Intestinal failure: from adaptation to transplantation].

作者信息

Messing B, Corcos O, Amiot A, Joly F

机构信息

Service de Gastroentérologie et Assistance Nutritive, Centre Agréé de Nutrition Parentérale à Domicile, Labellisé Pour les Maladies Intestinales Rares et la Transplantation Intestinale, Pôle des Maladies de l'Appareil Digestif, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, 92110 Clichy, France.

出版信息

Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):648-59. doi: 10.1016/j.gcb.2009.07.012. Epub 2009 Aug 18.

Abstract

Optimised Home Parenteral Nutrition is still, after 35 years of progress, the << gold standard >> of benign but chronic Intestinal Failure. A better recognition of chronic Intestinal Failure, in its multiple facets, is warranted for a better approach of associated treatment to Home Parenteral Nutrition, i.e., intestinal trophic factors (growth hormone, Glucagon Like Peptide-2), rehabilitative surgery (reestablishment of colonic continuity, reverse jejunal segment in severe short gut type II) and/or reconstructive surgery (intestinal transplantation for end stage intestinal failure patients). Boundaries of permanent, judged irreversible, intestinal failure will be certainly modified in the following years by combining the various and effective therapies which optimise management by ameliorating absorption of the remnant short gut. The work done on short bowel syndrome in the past 20 years should be done in the next years for chronic-intestinal - pseudo-obstruction patients presenting with intestinal failure on a large European scale because chronic-intestinal - pseudo-obstruction is a group of heterogeneous but rare intestinal diseases. Intestinal transplantation is now a mature therapy with formal indication especially in case of Home Parenteral Nutrition failure (mainly Home Parenteral Nutrition-associated severe liver disease) where combined Liver-intestine transplantation is indicated before end-stage liver failure occurs. For high-risk patients, "preemptive" indication for intestinal transplantation alone will be discussed before home parenteral nutrition complications occur. No doubt that, for improving overall outcome in intestinal failure patients, reference centres should have in expert hands the whole spectrum of medicosurgical therapies for intestinal failure.

摘要

经过35年的发展,优化的家庭肠内营养仍然是良性慢性肠衰竭的“金标准”。为了更好地将相关治疗与家庭肠内营养相结合,即肠营养因子(生长激素、胰高血糖素样肽-2)、康复手术(重建结肠连续性、严重短肠II型的逆行空肠段)和/或重建手术(为终末期肠衰竭患者进行肠移植),有必要更全面地认识慢性肠衰竭的多个方面。通过结合各种有效的治疗方法来改善残余短肠的吸收,从而优化管理,未来几年,永久性、被判定为不可逆的肠衰竭的界限肯定会被改变。在过去20年里针对短肠综合征所做的工作,未来几年应该在欧洲大规模地针对患有肠衰竭的慢性肠假性梗阻患者开展,因为慢性肠假性梗阻是一组异质性但罕见的肠道疾病。肠移植现在是一种成熟的治疗方法,有明确的适应症,特别是在家庭肠内营养失败(主要是家庭肠内营养相关的严重肝病)的情况下,在终末期肝功能衰竭发生之前应进行肝肠联合移植。对于高危患者,在家庭肠内营养并发症发生之前,将讨论单独进行肠移植的“预防性”适应症。毫无疑问,为了改善肠衰竭患者的总体治疗效果,参考中心应该由专家掌握针对肠衰竭的所有药物和手术治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验